Cargando…

Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy

Human breast cancer treatment regimens have evolved greatly due to the significant advances in understanding the molecular mechanisms and pathways of the common subtypes of breast cancer. In this review, we discuss recent progress in breast cancer targeted therapy and immunotherapy as well as ongoin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bou-Dargham, Mayassa J., Draughon, Sophia, Cantrell, Vance, Khamis, Zahraa I., Sang, Qing-Xiang Amy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558657/ https://www.ncbi.nlm.nih.gov/pubmed/34729098 http://dx.doi.org/10.7150/jca.64205

Ejemplares similares

Evidence for a Proapoptotic Role of Matrix Metalloproteinase-26 in Human Prostate Cancer Cells and Tissues
por: Khamis, Zahraa I., et al.
Publicado: (2016)

Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2020)

Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2020)

Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2018)

Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups
por: Robbins, Charles J., et al.
Publicado: (2018)

TCGA RNA-Seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2023)

Personalized chemotherapy selection for breast cancer using gene expression profiles
por: Yu, Kaixian, et al.
Publicado: (2017)

Active Roles of Tumor Stroma in Breast Cancer Metastasis
por: Khamis, Zahraa I., et al.
Publicado: (2012)

Novel Stromal Biomarkers in Human Breast Cancer Tissues Provide Evidence for the More Malignant Phenotype of Estrogen Receptor-Negative Tumors
por: Khamis, Zahraa I., et al.
Publicado: (2011)

TIPE polarity proteins are required for mucosal deployment of T lymphocytes and mucosal defense against bacterial infection
por: Li, Mingyue, et al.
Publicado: (2021)

Protein Profiling of Isolated Leukocytes, Myofibroblasts, Epithelial, Basal, and Endothelial Cells from Normal, Hyperplastic, Cancerous, and Inflammatory Human Prostate Tissues
por: Khamis, Zahraa I., et al.
Publicado: (2010)

The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells
por: Khamis, Zahraa I., et al.
Publicado: (2013)

Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
por: Khamis, Zahraa I., et al.
Publicado: (2021)

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
por: Ye, Feng, et al.
Publicado: (2023)

Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma
por: Du, Jiajia, et al.
Publicado: (2023)

Advances in targeted therapy and immunotherapy for melanoma (Review)
por: Qin, Ziyao, et al.
Publicado: (2023)

Advances in targeted therapy and immunotherapy for esophageal cancer
por: Yang, Haiou, et al.
Publicado: (2023)

Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer
por: Stewart, Paul A., et al.
Publicado: (2017)

Modeling Human Brain Tumors and the Microenvironment Using Induced Pluripotent Stem Cells
por: Khamis, Zahraa I., et al.
Publicado: (2023)

Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
por: Sun, Xiaolu, et al.
Publicado: (2022)

Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
por: Wilmott, James S., et al.
Publicado: (2012)

Novel targeted therapies and immunotherapy for advanced thyroid cancers
por: Naoum, George E., et al.
Publicado: (2018)

Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
por: Laface, Carmelo, et al.
Publicado: (2023)

Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
por: Shi, Jinhong, et al.
Publicado: (2020)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
por: Xue, Jian, et al.
Publicado: (2021)

Target discovery for T cell therapy: next steps to advance Immunotherapies
por: Bot, Adrian, et al.
Publicado: (2015)

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma
por: Russo, Irene, et al.
Publicado: (2018)

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2021)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma
por: Olszanski, Anthony J.
Publicado: (2014)

Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy
por: Cheng, Yuan, et al.
Publicado: (2021)

Advances in Targeted Immunotherapy for Hepatobiliary Cancers
por: Ruff, Samantha M., et al.
Publicado: (2022)

Combined targeted therapy and immunotherapy for cancer treatment
por: Guo, Cheng-Xiang, et al.
Publicado: (2021)

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy
por: Niezgoda, Anna, et al.
Publicado: (2015)

Research advances in the targeted therapy and immunotherapy of Wilms tumor: a narrative review
por: Hong, Bo, et al.
Publicado: (2021)

MET-11 Recent advances in targeted therapies and immunotherapy for metastatic brain tumors
por: Ando, Yuichi
Publicado: (2021)

Editorial: Advancements in immunology and immunotherapy for breast cancer
por: Sugie, Tomoharu, et al.
Publicado: (2022)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
por: Plachouri, Kerasia-Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_biq6l7toiii6m1mpl1ak6hln6o